News | January 25, 2025
Merck inaugurates expansion of its Peenya facility in Bengaluru
Expansion makes Merck Life Science in Bengaluru a key manufacturing location in the APAC region
Expansion makes Merck Life Science in Bengaluru a key manufacturing location in the APAC region
Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture and commercialize HS-10535
Merck will record a pre-tax charge relating to the upfront payment of $588 million
Merck has also decided to end the favezelimab clinical development program
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
An investigational long-acting monoclonal antibody designed to protect infants from RSV disease during their first RSV season
Based on data, 1.75 mg/kg dose established as recommended dose for Phase 3 trial of this investigational antibody-drug conjugate
The initiative will encourage and motivate emerging biotech startups, innovators and entrepreneurs
WINREVAIR met primary endpoint of time to first morbidity or mortality event for the treatment of patients with pulmonary arterial hypertension (PAH) functional class III or IV at high risk of mortality
With the addition of Karsanbhai, the Merck board will consist of 13 members
Subscribe To Our Newsletter & Stay Updated
